NZ264420A - Quinoline derivatives and medicaments thereof - Google Patents

Quinoline derivatives and medicaments thereof

Info

Publication number
NZ264420A
NZ264420A NZ264420A NZ26442094A NZ264420A NZ 264420 A NZ264420 A NZ 264420A NZ 264420 A NZ264420 A NZ 264420A NZ 26442094 A NZ26442094 A NZ 26442094A NZ 264420 A NZ264420 A NZ 264420A
Authority
NZ
New Zealand
Prior art keywords
lower alkyl
formula
compound
hydrogen
acid
Prior art date
Application number
NZ264420A
Other languages
English (en)
Inventor
Sprecher Andreas Von
Andreas Beck
Marc Gerspacher
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ264420A publication Critical patent/NZ264420A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ264420A 1993-09-10 1994-09-08 Quinoline derivatives and medicaments thereof NZ264420A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810645 1993-09-10

Publications (1)

Publication Number Publication Date
NZ264420A true NZ264420A (en) 1996-06-25

Family

ID=8215029

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ264420A NZ264420A (en) 1993-09-10 1994-09-08 Quinoline derivatives and medicaments thereof

Country Status (20)

Country Link
US (1) US5508408A (OSRAM)
JP (1) JP3652721B2 (OSRAM)
KR (1) KR950008483A (OSRAM)
CN (1) CN1054845C (OSRAM)
AT (1) ATE190307T1 (OSRAM)
AU (1) AU683481B2 (OSRAM)
CA (1) CA2131644C (OSRAM)
CZ (1) CZ284006B6 (OSRAM)
DE (1) DE59409179D1 (OSRAM)
ES (1) ES2144501T3 (OSRAM)
FI (1) FI944120A7 (OSRAM)
HU (1) HUT70556A (OSRAM)
IL (1) IL110864A0 (OSRAM)
NO (1) NO301639B1 (OSRAM)
NZ (1) NZ264420A (OSRAM)
PH (1) PH31094A (OSRAM)
PT (1) PT643045E (OSRAM)
SK (1) SK107394A3 (OSRAM)
TW (1) TW249802B (OSRAM)
ZA (1) ZA946957B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1177176E (pt) 1999-04-28 2006-08-31 Aventis Pharma Gmbh Derivados de acidos triarilicos como ligandos de receptores ppar.
IT1320162B1 (it) 2000-02-09 2003-11-18 Rotta Research Lab Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
US6531494B1 (en) * 2001-08-29 2003-03-11 Pharmacia Corporation Gem-substituted αvβ3 antagonists
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109009A (en) * 1985-03-08 1992-04-28 Leo Pharmaceutical Products Ltd. Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4962203A (en) * 1985-06-18 1990-10-09 Merck Frost Canada, Inc. 2-substituted quinolines useful as leukotriene antagonists
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
DE3682160D1 (de) * 1985-10-16 1991-11-28 Merck Frosst Canada Inc 2-substituierte chinoline.
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
JPS62145049A (ja) * 1985-12-18 1987-06-29 Mitsubishi Chem Ind Ltd アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
JPS63258854A (ja) * 1987-04-16 1988-10-26 Mitsubishi Kasei Corp カルボキシスチレン誘導体およびそれを有効成分とする薬剤
DE68913856T2 (de) * 1988-07-15 1994-10-20 Hoffmann La Roche Cycloalkylthiazol-Derivate.
JPH02275857A (ja) * 1989-01-13 1990-11-09 Yoshitomi Pharmaceut Ind Ltd ピリジン誘導体
CN1078151A (zh) * 1993-01-01 1993-11-10 周礼伯 天然药物成分的蚕药
CN1050999C (zh) * 1993-02-16 2000-04-05 胡祖良 抗病毒性蚕病的蚕药

Also Published As

Publication number Publication date
DE59409179D1 (de) 2000-04-13
NO301639B1 (no) 1997-11-24
HU9402585D0 (en) 1994-11-28
ZA946957B (en) 1995-04-18
JP3652721B2 (ja) 2005-05-25
HUT70556A (en) 1995-10-30
ES2144501T3 (es) 2000-06-16
AU683481B2 (en) 1997-11-13
FI944120A0 (fi) 1994-09-07
CA2131644C (en) 2007-04-24
SK107394A3 (en) 1995-05-10
US5508408A (en) 1996-04-16
PT643045E (pt) 2000-08-31
CN1054845C (zh) 2000-07-26
TW249802B (OSRAM) 1995-06-21
IL110864A0 (en) 1994-11-28
FI944120A7 (fi) 1995-03-11
AU7161794A (en) 1995-03-23
KR950008483A (ko) 1995-04-17
PH31094A (en) 1998-02-05
CA2131644A1 (en) 1995-03-11
NO943336D0 (no) 1994-09-09
ATE190307T1 (de) 2000-03-15
CZ218794A3 (en) 1995-03-15
NO943336L (no) 1995-03-13
CZ284006B6 (cs) 1998-07-15
JPH07179426A (ja) 1995-07-18
CN1105991A (zh) 1995-08-02

Similar Documents

Publication Publication Date Title
AU666704B2 (en) Anthraquinone compounds and pharmaceutical compositions containing them
RU2354646C2 (ru) Нафталиновые производные
JPH0586391B2 (OSRAM)
EP0316630A1 (en) Novel fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
JPS61191683A (ja) 新規な酸性インド−ル化合物
CN104151200A (zh) Hdac抑制剂
CZ401397A3 (cs) Bicyklické aminoderiváty a antagonist PGD2, který je obsahuje
FI74279C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara trans-3-(4-oxo-4h-kinazolin-3-yl)-2- propensyraderivat.
CA1191140A (en) 2-quinolone derivatives
US5248693A (en) Acetylene compounds and pharmaceutical compositions and methods of using the same
EP0199393B1 (en) Indene and naphthalene derivatives
CA2399451C (en) Tyrosine derivatives with anti-leukotriene activity
AU683481B2 (en) Quinoline compounds
PL106659B1 (pl) Sposob wytwarzania nowych pochodnych pirazolo/1,5-c/chinazoliny
NZ245328A (en) Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives, preparation and pharmaceutical compositions thereof
EP0055068A1 (en) Quinolone derivatives and their use as pharmaceuticals
US5523310A (en) 1,2,3-triazole derivatives
JPS6335623B2 (OSRAM)
US4853406A (en) Polyhydrobenzi[c,d]indolesulphonamides
WO1997044313A1 (en) N,N'-Di(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES
SK86593A3 (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
EP0643045B1 (de) Chinolin-Verbindungen als Leukotriene Antagonisten
US5250541A (en) Kynurenic acid derivatives, their preparation and pharmaceutical compositions containing them
JPH02275846A (ja) カルボン酸誘導体
US5210230A (en) Lignan process